HMG CoA reductase inhibitors (statins) for dialysis patients-Reference-Cited by-同舟云学术

HMG CoA reductase inhibitors (statins) for dialysis patients

Published:2013-09-11 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Palmer Suetonia C¹,Navaneethan Sankar D²,Craig Jonathan C³⁴,Johnson David W⁵,Perkovic Vlado⁶,Nigwekar Sagar U⁷,Hegbrant Jorgen⁸,Strippoli Giovanni FM³⁴⁹¹⁰¹¹

Affiliation:

1. University of Otago Christchurch; Department of Medicine; 2 Riccarton Ave PO Box 4345 Christchurch New Zealand 8140

2. Glickman Urological and Kidney Institute, Cleveland Clinic; Department of Nephrology and Hypertension; Cleveland OH USA 44195

3. The University of Sydney; Sydney School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006

4. The Children's Hospital at Westmead; Cochrane Renal Group, Centre for Kidney Research; Westmead NSW Australia 2145

5. Princess Alexandra Hospital; Department of Nephrology; Ipswich Rd Woolloongabba Queensland Australia 4102

6. The George Institute for Global Health; Renal and Metabolic Division; Camperdown NSW Australia

7. Harvard Medical School; Brigham and Women's Hospital, Massachusetts General Hospital, Scholars in Clinical Sciences Program; Boston MA USA

8. Diaverum Renal Services Group; Medical Office; PO Box 4167 Lund Sweden SE-227 22

9. University of Bari; Department of Emergency and Organ Transplantation; Bari Italy 70100

10. Mario Negri Sud Consortium; Department of Clinical Pharmacology and Epidemiology; Santa Maria Imbaro Italy

11. Diaverum; Medical-Scientific Office; Lund Sweden

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004289.pub5/fullpdf

Reference141 articles.

1. The association between parathyroid hormone and mortality in dialysis patients is modified by wasting;Drechsler;Nephrology Dialysis Transplantation,2009

2. Glycemic control and cardiovascular events in diabetic hemodialysis patients;Drechsler;Circulation,2009

3. Increasing adiponectin is associated with cardiovascular events and mortality in diabetic patients on hemodialysis [abstract];Drechsler;Journal of the American Society of Nephrology,2008

4. Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes;Krane;Clinical Journal of The American Society of Nephrology: CJASN,2010

5. Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis;Krane;Clinical Journal of The American Society of Nephrology: CJASN,2009

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes of Renal Transplant Recipients Undergoing Percutaneous Coronary Intervention;Heart, Lung and Circulation;2024-07

2. Supplementation of Antioxidants in Chronic Kidney Disease: Clinical Necessity or Wishful Thinking? A Bench to Bedside Translational Research;Current Medicinal Chemistry;2024-06-20

3. Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in patients with end‐stage renal disease;European Journal of Clinical Investigation;2024-06-10

4. Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines;Cardiovascular Therapy and Prevention;2024-04-01

5. Myocardial infarction and stroke in patients with kidney failure: can we do better?;European Heart Journal;2024-03-27